Gene Therapy for Rare Disorders Virtual Conference 2021
Gene Therapy for Rare Disorders Conference (February 23-26)
Precision joins the Gene Therapy for Rare Disorders conference and will be hosting three presentations including a panel with GCTx innovators!
February 23, 5.30pm EST
Precision ADVANCE Panel Discussion- Considerations for early-stage gene therapy start-ups: from clinical development to manufacturing to commercialization
• Learn from industry experts how to anticipate and mitigate hurdles across the continuum
• Hear best practices to gain access to investment funding for the acceleration of your innovative gene therapy
• Learn key insights for building an effective cross-functional team to support the success of your project
February 24, 11.30am EST
Speaker: Deb Phippard, Global Head, Research
Planning for Success: Development of Diagnostic Assays for Gene Therapies
- Gene therapy assays
- When does an assay become a diagnostic?
- Navigating the regulatory jargon: LDT, IVD, IDE, PMA, and more
- Diagnostic assay implementation
- Commercialization considerations for rare disease assays
February, 23 at 1.30pm EST
Speaker: Kristin Ingrassia, Senior Director, Project Management
Challenges and Mitigations in Gene Therapy Rare Disease Trial Feasibility and Start-up
- Cultural Considerations and Gene Therapy Awareness
- Site/Facility Considerations
- The Implications of Country and Regulatory Dynamics on Site Selection